Atlas Trials

Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors

Clinical trial NCT05952687 · WITHDRAWN

Trial details

NCT number
NCT05952687
Sponsor
St. Jude Children's Research Hospital
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Rhabdoid TumorAtypical Teratoid/Rhabdoid TumorAtypical Teratoid/Rhabdoid Tumor of CNSCNS Tumor
Start date
2024-03-01
Primary completion
2025-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.